Showing results (141-150 of 319) with videos related to
Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancerHedy L Kindler, Gregory Friberg, Deepti A Singh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckEzra E W Cohen, Madeleine A Kane, Marcy A List, et al.Scientific Reports|August 25, 2017
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBLYi-Hung Carol Tan, Tamara Mirzapoiazova, Brian M Won, et al.Gynecologic Oncology|February 2, 2010
A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II ConsortiaHalla S Nimeiri, Amit M Oza, Robert J Morgan, et al.Lung Cancer (Amsterdam, Netherlands)|October 9, 2002
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I studyPhilip C Hoffman, Ezra E W Cohen, Gregory A Masters, et al.Genes, Chromosomes & Cancer|May 16, 2012
Differential expression of RON in small and non-small cell lung cancersRajani Kanteti, Soundararajan Krishnaswamy, Daniel Catenacci, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancerRebecca S Heist, Xiaofei Wang, Lydia Hodgson, et al.International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105Joseph K Salama, Thomas E Stinchcombe, Lin Gu, et al.Journal of Geriatric Oncology|February 25, 2019
Clinical prognostic model for older patients with advanced non-small cell lung cancerApar Kishor Ganti, Xiaofei Wang, Thomas E Stinchcombe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neckMichael T Milano, Daniel J Haraf, Kerstin M Stenson, et al.Pageof 32